Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL, Fletcher PD, Clark CN, Mummery CJ, Schott JM, Rossor MN, Fox NC, Crutch SJ, Rohrer JD, Warren JD (2018) Primary progressive aphasia: a clinical approach. J Neurol 265:1474–1490

Article  PubMed  PubMed Central  Google Scholar 

Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014

Article  PubMed  PubMed Central  Google Scholar 

Graff-Radford J, Duffy JR, Strand EA, Josephs KA (2012) Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. Parkinsonism Relat Disord 18:890–892

Article  PubMed  PubMed Central  Google Scholar 

Kremen SA, Mendez MF, Tsai PH, Teng E (2011) Extrapyramidal signs in the primary progressive aphasias. Am J Alzheimers Dis Other Demen 26:72–77

Article  PubMed  PubMed Central  Google Scholar 

Hodges JR, Patterson K (2007) Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol 6:1004–1014

Article  CAS  PubMed  Google Scholar 

Henry ML, Gorno-Tempini ML (2010) The logopenic variant of primary progressive aphasia. Curr Opin Neurol 23:633–637

Article  PubMed  PubMed Central  Google Scholar 

Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D (2015) Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85:40–47

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boman A, Svensson S, Boxer A, Rojas JC, Seeley WW, Karydas A, Miller B, Kagedal K, Svenningsson P (2016) Distinct lysosomal network protein profiles in Parkinsonian syndrome cerebrospinal fluid. J Parkinsons Dis 6:307–315

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parnetti L, Balducci C, Pierguidi L, De Carlo C, Peducci M, D’Amore C, Padiglioni C, Mastrocola S, Persichetti E, Paciotti S, Bellomo G, Tambasco N, Rossi A, Beccari T, Calabresi P (2009) Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. Neurobiol Dis 34:484–486

Article  CAS  PubMed  Google Scholar 

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VMY (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133

Article  ADS  CAS  PubMed  Google Scholar 

Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73–96

Article  CAS  PubMed  Google Scholar 

Scotter EL, Vance C, Nishimura AL, Lee YB, Chen HJ, Urwin H, Sardone V, Mitchell JC, Rogelj B, Rubinsztein DC, Shaw CE (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci 127:1263–1278

CAS  PubMed  PubMed Central  Google Scholar 

Jiang S, Bhaskar K (2020) Degradation and transmission of tau by autophagic-endolysosomal networks and potential therapeutic targets for tauopathy. Front Mol Neurosci 13:586731

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blennow K, Zetterberg H, Fagan AM (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med. 2(9):a006221

Article  PubMed  PubMed Central  Google Scholar 

Brinkmalm G, Sjödin S, Simonsen AH, Hasselbalch SG, Zetterberg H, Brinkmalm A, Blennow K (2018) A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer’s disease. Proteomics Clin Appl 12:1700131

Article  Google Scholar 

Sjödin S, Brinkmalm G, Öhrfelt A, Parnetti L, Paciotti S, Hansson O, Hardy J, Blennow K, Zetterberg H, Brinkmalm A (2019) Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease. Alzheimers Res Ther 11:82

Article  PubMed  PubMed Central  Google Scholar 

MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaidi N, Maurer A, Nieke S, Kalbacher H (2008) Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun 376:5–9

Article  CAS  PubMed  Google Scholar 

Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D (2012) Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 1824:68–88

Article  CAS  PubMed  Google Scholar 

Schwagerl AL, Mohan PS, Cataldo AM, Vonsattel JP, Kowall NW, Nixon RA (1995) Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J Neurochem 64:443–446

Article  CAS  PubMed  Google Scholar 

Valdez C, Wong YC, Schwake M, Bu G, Wszolek ZK, Krainc D (2017) Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum Mol Genet 26:4861

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lemieux MJ, Mark BL, Cherney MM, Withers SG, Mahuran DJ, James MNG (2006) Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol 359:913–929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolter T, Sandhoff K (2010) Lysosomal degradation of membrane lipids. FEBS Lett 584:1700–1712

Article  CAS  PubMed  Google Scholar 

Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S (2007) LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J 26:313–324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saftig P, Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10:623–635

Article  CAS  PubMed  Google Scholar 

Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH (2009) Alterations in lysosomal and proteasomal markers in Parkinson’s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 35:385–398

Article  CAS  PubMed  Google Scholar 

Armstrong A, Mattsson N, Appelqvist H, Janefjord C, Sandin L, Agholme L, Olsson B, Svensson S, Blennow K, Zetterberg H, Kågedal K (2014) Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer’s disease. Neuromolecular Med 16:150–160

Article  CAS  PubMed  Google Scholar 

Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2(5):a006270

Article  PubMed  PubMed Central  Google Scholar 

Müller UC, Zheng H (2012) Physiological functions of APP family proteins. Cold Spring Harb Perspect Med. 2(2):a006288

Article  PubMed  PubMed Central  Google Scholar 

McMahon HT, Boucrot E (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12:517–533

Article  CAS  PubMed  Google Scholar 

Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425–479

Article  CAS  PubMed  Google Scholar 

Komander D, Rape M (2012) The ubiquitin code. Annu Rev Biochem 81:203–229

Article  CAS  PubMed  Google Scholar 

Blennow kaj T, Davidsson P, Wallin A, Gottfries CG, Svennerholm L, (1994) Ubiquitin in cerebrospinal fluid in Alzheimer’s disease and vascular dementia. Int Psychogeriatr 6:13–22

Article  Google Scholar